President and CEO of the Central Indiana Corporate Partnership
Director, Life Sciences Institute, University of Michigan
Medical College of Wisconsin director of research commercialization
VP of Research & Policy, Ewing Marion Kauffman Foundation
Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many opportunities for scientists to create a customized program based on personal interests. New this year is “Epigenetic Inhibitor Discovery,” which nicely complements the most popular topics from previous years: Anti-Inflammatories, Protein-Protein Interactions, Macrocyclics and Constrained Peptides, Fragment-Based Drug Discovery, and Kinase Inhibitor Chemistry. More information and online registration is here.